Alma
United States
- New York, New York
- 25/08/2022
- Series D
- $130,000,000
At Alma, we’re making it easier for consumers to access high-quality, affordable mental health care by supporting providers in building thriving private practices. We believe that when therapists have better resources, they’re able to provide better care to their clients. When a provider joins Alma, they gain access to a suite of tools that not only help them better run their business, but also grow it sustainably and develop as a provider. Our consumer experience is designed to empower people in their search for mental health care, offering multiple pathways and individualized support, if and when someone needs it. We’ve raised $90.5M from incredible investors like Insight Partners, Tusk, Primary, Optum Ventures, and First Round and were named one of Fast Company’s Most Innovative Companies in Health in 2020.
- Industry Mental Health Care
- Website https://helloalma.com/
- LinkedIn https://www.linkedin.com/company/withalma/
Parhelia Biosciences | Undisclosed Amount | (Oct 18, 2023)
Cloover | $7,388,000 | (Oct 18, 2023)
Hallmark Health Care Solutions | Undisclosed Amount | (Oct 18, 2023)
Prove | $40,000,000 | (Oct 18, 2023)
Reality Defender | $15,000,000 | (Oct 18, 2023)
Yardstik | $12,000,000 | (Oct 18, 2023)
Nucleus RadioPharma | $56,000,000 | (Oct 18, 2023)
Society Brands | $25,000,000 | (Oct 18, 2023)
Nova Credit | $45,000,000 | (Oct 18, 2023)
Anonybit | $3,000,000 | (Oct 18, 2023)
Zelus Analytics | Undisclosed Amount | (Oct 18, 2023)
Scorability | $11,000,000 | (Oct 18, 2023)